Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

NCT00761631 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1200
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer